EP3729100
Aðferð til að meta vaxtarhormónaskort í manneskjum með samsetningu sem inniheldur masímórelín
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.12.2018EP published:
23.3.2022EP application number:
18827044.1
EP translation filed:
28.4.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
17.12.2038Expiry date:
17.12.2026Next due date:
31.12.2026
Title in English:
METHOD OF ASSESSING GROWTH HORMONE DEFICIENCY IN HUMANS BY A MACIMORELIN CONTAINING COMPOSITIONLanguage of the patent:
English
Timeline
Today
18.12.2018EP application
23.3.2022EP Publication
28.4.2022Translation submitted
15.6.2022Registration published
17.12.2026Expires
Owner
Name:
Aeterna Zentaris GmbhAddress:
Weismüllerstrasse 50, 60314 Frankfurt, DE
Inventor
Name:
AMMER, NicolaAddress:
60435 Frankfurt am Main, DE
Name:
MUELLER, GilbertAddress:
60598 Frankfurt am Main, DE
Name:
SACHSE, RichardAddress:
88441 Mittelbiberach, DE
Name:
SINDERMANN, HerbertAddress:
26529 Upgant-Schott, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762607866 PDate:
19.12.2017Country:
US
Number:
201762609059 PDate:
21.12.2017Country:
US
Classification
Categories:
G01N 33/74, G01N 33/50
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 13.12.2022
Expires: 17.12.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 6
Paid: 12.12.2023
Expires: 17.12.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 10.12.2024
Expires: 17.12.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 8
Paid: 11.12.2025
Expires: 17.12.2026
Payer: G.H. Sigurgeirsson ehf.